A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis

dc.creatorConde, Marcus B.
dc.creatorMello, Fernanda C. Q.
dc.creatorDuarte, Rafael Silva
dc.creatorCavalcante, Solange C.
dc.creatorRolla, Valeria
dc.creatorDalcolmo, Margareth
dc.creatorLoredo, Carla
dc.creatorDurovni, Betina
dc.creatorArmstrong, Derek T.
dc.creatorEfron, Anne
dc.creatorBarnes, Grace L.
dc.creatorMarzinke, Mark A.
dc.creatorSavic, Radojka M.
dc.creatorDooley, Kelly E.
dc.creatorCohn, Silvia
dc.creatorMoulton, Lawrence H.
dc.creatorChaisson, Richard E.
dc.creatorDorman, Susan E.
dc.date.accessioned2019-02-22T14:57:39Z
dc.date.accessioned2023-09-05T15:27:02Z
dc.date.available2019-02-22T14:57:39Z
dc.date.available2023-09-05T15:27:02Z
dc.date.created2019-02-22T14:57:39Z
dc.date.issued2016
dc.identifierCONDE, Marcus B. et al. A phase 2 randomized trial of a Rifapentine plus Moxifloxacin-based regimen for treatment of pulmonary tuberculosis. Plos One, p.1-13, May 9, 2016.
dc.identifier1932-6203
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/31845
dc.identifier10.1371/journal.pone.0154778
dc.identifier1932-6203
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8666187
dc.languageeng
dc.publisherPublic Library of Science
dc.rightsopen access
dc.titleA phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis
dc.typeArticle


Este ítem pertenece a la siguiente institución